Also listed on Optiscan Biomedical Corporation, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends May 19, 2028 · High confidence
20-year base term ends May 19, 2028
May 19, 2008
May 19, 2028
Jun 9, 2020
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 1 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 19, 2008, when application 12/123,422, the earliest non-provisional in its chain, was filed (this one was filed Apr 18, 2017) | May 19, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,632,013) | resolves to May 19, 2028, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 19, 2028 | High confidence |
This family
| US 8,470,241 | In force Feb 2032 | Feb 2032 |
| US 8,412,293 | In force Aug 2031 | Aug 2031 |
| Application 12/247,956 | Abandoned not computed | not computed |
| US 7,972,296 | In force Oct 2028 | Oct 2028 |
| Application 12/251,339 | Abandoned not computed | not computed |
| Application 12/251,357 | Abandoned not computed | not computed |
| Application 12/546,568 | Abandoned not computed | not computed |
| US 8,417,311 | In force Jun 2030 | Jun 2030 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 3, 2019 Reel 48783, frame 252 | Rivas, Gil; Butler, Michael; Chiou, Jeffrey T.; Lim, Eugene; Keenan, Richard | Optiscan Biomedical Corporation | Assignment of Assignor's Interest |
| Mar 25, 2020 Reel 52227, frame 435 | Optiscan Biomedical Corporation | East West Bank | Security Interest |
| Mar 31, 2021 Reel 55782, frame 458 | East West Bank | Insulet Corporation | Assignment of Assignor's Interest |
| May 4, 2021 Reel 56135, frame 974 | Insulet Corporation | Morgan Stanley Senior Funding, Inc., as Collateral Agent | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 9,632,013, ends no earlier than this term, so it caps nothing.